Indications |
Oral Hypertension Adult: 200 mcg once daily, increase if necessary after 3 wk to 400 mcg daily as single or in 2 divided doses. If necessary, after a further 3 wk, increase to 600 mcg daily in 2 divided doses. Max: 600 mcg daily.
Special Populations: Dose reduction in renal impairment. |
||||||
Contraindications |
Conduction disorders; bradycardia; severe arrhythmias; severe heart failure; severe ischaemic heart disease; history of angioedema; severe liver or renal impairment; Raynaud's syndrome; intermittent claudication; epilepsy; depression; Parkinson's disease; glaucoma. Pregnancy and lactation. | ||||||
Warnings / Precautions |
Renal impairment; avoid abrupt withdrawal (if concomitant treatment with β-blocker has to be stopped, discontinue β-blocker first, then moxonidine after few days). | ||||||
Adverse Reactions |
Dry mouth; headache; fatigue; dizziness; nausea; sleep disturbances; asthenia; vasodilatation; skin reactions; constipation; depression; anxiety; anorexia; parotid pain; vivid dreams; impotence and loss of libido; urinary retention or incontinence; slight orthostastic hypotension; fluid retention. | ||||||
Drug Interactions |
Additive effects with other antihypertensives; may increase sedative effects of benzodiazepines. Effects may be antagonised by TCAs. See Below for More moxonidine Drug Interactions |
||||||
Mechanism of Actions |
Moxonidine is a centrally-acting antihypertensive. It acts in the brainstem through stimulation of central imidazoline receptors to reduce sympathetic tone. Moxonidine also has a low affinity for α2-adrenoceptors. Absorption: Absorbed rapidly from the GI tract. Distribution: Plasma protein binding around 7%; present in breast milk. Excretion: Excreted in the urine (78% as unchanged drug). |
||||||
Administration |
May be taken with or without food. |
||||||
ATC Classification |
C02AC05 - moxonidine ; Belongs to the class of imidazoline receptor agonists, centrally-acting antiadrenergic agents. Used in the treatment of hypertension. | ||||||
Available As |
|
Moxonidine
Post Review about Moxonidine Click here to cancel reply.
Moxonidine Containing Brands
Moxonidine is used in following diseases
Drug - Drug Interactions of Moxonidine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.